Providence Health & Services
Clinical trials sponsored by Providence Health & Services, explained in plain language.
-
Cancer vaccine plus immune boosters aim to shrink head and neck tumors
Disease control Recruiting nowThis early-phase trial tests a combination of a cancer vaccine (DPV-001) and two immunotherapy drugs (GITR agonist and anti-PD-1) in people with head and neck cancer that has returned or spread. The goal is to see if this approach is safe and helps control the disease. About 56 a…
Phase: PHASE1 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New drug combo aims to boost immune response in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests whether adding an experimental drug (GB1211) to standard immunotherapy (pembrolizumab) works better than immunotherapy alone for people with advanced melanoma or head and neck cancer. About 92 participants will receive either the combination or a placebo plus pem…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo aims to shrink tough breast tumors before chemo
Disease control Recruiting nowThis study tests whether adding an experimental drug (INBRX-106) to an approved immunotherapy (pembrolizumab) can shrink tumors in people with stage II or III triple-negative breast cancer before they start standard chemotherapy. About 12 adults with measurable tumors will receiv…
Phase: PHASE2 • Sponsor: Providence Health & Services • Aim: Disease control
Last updated May 05, 2026 11:56 UTC